STING1 and renal cell carcinoma: Like STING depletion (Figure 5I), 2‐BP treatment led to reduced mTORC1/S6K signaling in A498 cells (Figure S8W, Supporting Information), further supporting mTORC1/S6K as one of the signaling downstream of STING in regulating RCC growth.